Vials are seen on a tray in a lab at Sinovac Biotech where the company is producing their potential COVID-19 vaccine CoronaVac during a media tour on Sept 24, 2020 in Beijing, China. (PHOTO / BLOOMBERG)

BEIJING - The Ministry of Industry and Information Technology has moved to facilitate corporate cooperation along industrial chains to accelerate the industrialization of COVID-19 vaccines and expand production capacity to ensure the supply of vaccines, an official said Tuesday.

Wang Jiangping, vice minister of industry and information technology, said the country's production capacity will be steadily expanded while ensuring the quality and safety of vaccines.

Wang Jiangping, vice minister of industry and information technology, said the country's production capacity will be steadily expanded while ensuring the quality and safety of vaccines

Production plans will be properly arranged to maximize production potential and ensure the supply of COVID-19 vaccines, Wang said. 

ALSO READ: China approves self-developed COVID-19 vaccine

The ministry has established a special work team to track and coordinate vaccine production by key producers on a weekly basis.

To ensure a stable supply chain for vaccine production, the country has also stepped up efforts to achieve breakthroughs in the production of core materials, and helped match the supply and demand of upstream and downstream firms.

ALSO READ: China starts building COVID-19 vaccine production facility

With 18 Chinese enterprises starting to build production capacity for COVID-19 vaccines so far, further improvement of the manufacturing capacity of the inactivated vaccines will allow China to meet its huge vaccination demand, according to the MIIT.

Zhang Jin, a manager at the China National Biotec Group, said the company will implement a plan to expand production capacity and to ensure that more than one billion doses of inactivated COVID-19 vaccines are produced this year.

READ MORE: Chinese vaccines show effective protection against COVID-19